Blog Entry List
Effective with date of service May 15, 2023, NC Medicaid covers pegfilgrastim-pbbk injection, for subcutaneous use (Fylnetra).
Updates include updated policies on Acuity Tiers, Acuity-Based Contacts and Contact Monitoring.
Effective with date of service April 21, 2023, NC Medicaid covers paclitaxel protein-bound particles for injectable suspension, (albumin-bound)
A draft application for § 1915 (c) NC Innovation Waiver is posted for a 30-day public comment period.
The North Carolina Department of Health and Human Services recently awarded Acentra Health the contract as the Comprehensive Independent Assessment Entity (CIAE) for NC Medicaid. Acentra Health will provide management and oversight for the Preadmission Screening Resident Review (PASRR) Level II process and will also serve as the Local Contact Agency (LCA), responsible for providing interested Nursing Facility (NF) residents with options for transitioning from institutional care to community-based living.
This bulletin provides details on coverage for COVID-19 Vaccines and COVID-19 Counseling after the ending of the Federal Public Health Emergency.
Effective July 1, 2023, NC Medicaid has increased the Medicaid rate for Maternal Bundled Payments for pregnancy care.
Beneficiaries who will be covered by the Tailored Plans will continue to receive care as they do today.
Effective Jan. 1, 2023, the location field must have a valid value of 1 or 2.
The report and instructions for completing the report are updated to capture additional information needed for Credit Balance Audits
Includes an overview of the newest Center for Medicare and Medicaid Innovation payment model for Medicare, NC Medicaid’s involvement and timelines.
New Temporary/Interim Estimated Budget Increases Added July 1, 2023.
Allows Home and Community Based Services for individuals with behavioral health, intellectual/developmental disabilities and traumatic brain injury.
Effective with date of service April 5, 2023, NC Medicaid covers retifanlimab-dlwr injection, for intravenous use (Zynyz)
Effective with date of service April 4, 2023, NC Medicaid covers velmanase alfa-tycv for injection, for intravenous use (Lamzede)